Abstract Submission

Download Abstract Template

Agenda Topics

    • High Throughput Screening
    • Hit and Lead Identification
    • Assay Development
    • Lead Generation and Optimization
    • In Vivo and In Vitro Assays
    • Screening Compound Libraries
    • Synthetic Organic Chemistry
    • Computational Chemistry

    • Lead Optimization
    • Developing a Drug from an Optimized Lead
    • Structure based Drug Designing
    • Case studies of Successful Drugs
    • Pre-Clinical Research
    • Clinical Research
    • Artificial Intelligence
    • Pharmacophore & Virtual Screening

    • Ubiquitin-Induced Protein Degradation
    • Fragment-Based Drug Discovery
    • Kinase Inhibitor Chemistry
    • Macrocyclics & Constrained Peptides
    • Protein-Protein Interactions
    • Small Molecules for Immunology & Oncology
    • Encoded Libraries for Small Molecule Discovery
    • Lead Optimization for Drug Metabolism

    • Target Identification and Validation
    • Quantitation of Drug Effects
    • The Diversity of Molecular Drug Targets
    • Cell Signalling Modalities
    • Pharmacotherapy
    • Pharmacodynamics & Pharmacokinetics
    • Drug-Target Interactions
    • RNA as a Small Molecule Target

    • Preclinical Investigation
    • Clinical Investigation
    • Drug Application Review
    • Postmarketing Surveillance
    • Regulatory Process

    • Data Digitalization
    • AI: Networks and Tools
    • AI in the Lifecycle of Pharmaceutical Products
    • AI in Designing Drug Molecules
    • AI in de novo Drug Design
    • AI in Advancing Pharmaceutical Product Development
    • AI in Pharmaceutical Manufacturing
    • AI in Quality Control and Quality Assurance
    • AI in Clinical Trial Design
    • AI in Pharmaceutical Product Management
    • AI in Market Positioning
    • AI in Market Prediction and Analysis
    • AI in Product Cost
    • AI-based Nanorobots for Drug Delivery
    • AI in Combination Drug Delivery and Synergism/Antagonism Prediction
    • AI Emergence in Nanomedicine
    • Pharmaceutical Market of AI
    • Ongoing Challenges In Adopting AI: Leads on Ways to Overcome

Reasons to Submit Abstract

  • Opportunity to interact with an exceptional group of speakers, including federal officers and top-tier researchers from both industry and academia.
  • Broaden your horizons: the congress welcomes scientists, experts, technocrats, and researchers from developed and developing nations, offering a truly global perspective.
  • Share your expertize worldwide: contribute your research findings, teaching methods, and exemplary practices to advance knowledge dissemination on a global scale.
  • All the accepted abstracts will be published.
  • Opportunity to publish full length article in a SCOPUS INDEXED Journal (subjective to confirmation).

Guidelines for Abstract Submission

Tips for submitting an abstract:

  • Title: Keep your title brief and descriptive to accurately represent your research.
  • Authors: List all authors and their affiliations, making sure to identify the presenting author.
  • Introduction: Clearly explain the background and objectives of your study, along with the motivation behind your research.
  • Methods: Describe the methods or approaches used in your study, including details about experimental design and data collection.
  • Results: Summarize the main findings of your study, supported by relevant data and statistical analyses.
  • Discussion: Interpret your results and discuss their implications, comparing them to previous research and suggesting areas for future study.
  • Conclusion: Summarize the main conclusions drawn from your study and explain their significance for the field.
  • Keywords: Include 3-5 keywords that highlight the main topics or concepts covered in your abstract.
  • Formatting: Follow the formatting guidelines provided by the organizer and proofread your abstract for errors.
  • Submission Instructions: Adhere to the submission deadlines and instructions provided by the organizer.
  • Ethical Considerations: Ensure that your research complies with ethical guidelines and regulations, providing any necessary information regarding ethical approval or informed consent.
  • Clarity and Conciseness: Keep your abstract clear, concise, and focused, avoiding unnecessary technical jargon or excessive detail.

General Guidelines for Lectures and Presentations

Types of contributions:

  • 1. Keynote Talk: Total time- 30 mins; 25 mins presentation followed by 5 mins Q&A.
  • 2. Invited Oral Talk: Total time- 20 mins; 17 mins presentation followed by 3 mins Q&A.
  • 3. Podium Presentation: Total time- 15 mins; 12 mins presentation followed by 3 mins Q&A.
  • 4. Flash Presentation: Total time- 10 mins; 8 mins presentation followed by 2 mins Q&A.

PowerPoint Format for Speakers

For optimal broadcasting, it's recommended to use the 16:9 format for your PowerPoint presentation. When converting from 4:3 to 16:9, ensure that figures maintain their original proportions and do not become stretched. If stretching occurs, utilize the option in the figure-size menu to restore the original size. Keep presentations light, clear, and concise by minimizing text, animations, and videos.

Guidelines for Poster

  • 1. Physical Poster: The standard poster display size 1 meter by 1 meter Posters need to be displayed in the specific location assigned.
  • 2. Poster Format:
    • Title: Place at the top center using 72-point letters.
    • Use digital tools; avoid hand-drawn materials.
    • Keep it simple; avoid clutter.
    • Avoid replicating paper pages; condense information.
    • Ensure a logical flow; organize content clearly.
    • Utilize visuals: color, graphics, charts, photos.
    • Highlight key points with bold or larger font.
    • Avoid overloading information; focus on highlights.
    • Reserve key points for one-on-one discussion.
    • Confirm setup and presentation time in the conference program session.

320 Washington St, Newton, MA 02458, United States

+1-512-539-0539

contact@drugrnd.com